• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[杀菌率在儿童重症葡萄球菌感染初始治疗中的作用]

[Contribution of bactericidal rate in the initial treatment of severe staphylococcal infections in children].

作者信息

Bingen E, Lambert-Zechovsky N, Beaufils F, Mercier J C, Cohen R, Roze J C

机构信息

Laboratoire de Bactériologie, Hôpital Bretonneau, Paris.

出版信息

Arch Fr Pediatr. 1988 Jan;45(1):61-4.

PMID:3365107
Abstract

Rapid bactericidal effect is essential for therapy of severe Staphylococcus aureus infections in children. The in vitro activity of clinically achievable levels of vancomycin and its combinations with gentamicin, amikacin and rifampin plus amikacin was studied with the time-kill curve method at 2.5, 4, 6, 24 and 48 hours against 20 strains of Staphylococcus aureus isolated from children with severe staphylococcal infection. Vancomycin alone exerted a bactericidal effect at 48 hours. However, with the combinations vancomycin plus gentamicin, vancomycin plus amikacin and vancomycin plus amikacin plus rifampin a bactericidal effect was respectively observed at 24, 6 and 4 hours. Most rapid killing was achieved with vancomycin plus rifampin plus amikacin. Thus this antibiotic combination seems the most appropriate for initial treatment of severe staphylococcal infections in children.

摘要

快速杀菌作用对于儿童严重金黄色葡萄球菌感染的治疗至关重要。采用时间杀菌曲线法,研究了临床可达到水平的万古霉素及其与庆大霉素、阿米卡星的组合以及利福平加阿米卡星在2.5、4、6、24和48小时对从患有严重葡萄球菌感染的儿童中分离出的20株金黄色葡萄球菌的体外活性。单独使用万古霉素在48小时时发挥杀菌作用。然而,万古霉素加庆大霉素、万古霉素加阿米卡星以及万古霉素加阿米卡星加利福平的组合分别在24、6和4小时时观察到杀菌作用。万古霉素加利福平加阿米卡星实现了最快的杀菌效果。因此,这种抗生素组合似乎最适合儿童严重葡萄球菌感染的初始治疗。

相似文献

1
[Contribution of bactericidal rate in the initial treatment of severe staphylococcal infections in children].[杀菌率在儿童重症葡萄球菌感染初始治疗中的作用]
Arch Fr Pediatr. 1988 Jan;45(1):61-4.
2
Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.耐甲氧西林表皮葡萄球菌实验性心内膜炎的治疗
J Lab Clin Med. 1982 Jul;100(1):94-104.
3
In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.利奈唑胺单独及与庆大霉素、万古霉素或利福平联合应用对耐甲氧西林金黄色葡萄球菌的体外杀菌活性:时间杀菌曲线法研究
J Antimicrob Chemother. 2003 Apr;51(4):857-64. doi: 10.1093/jac/dkg160. Epub 2003 Mar 13.
4
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.利奈唑胺联合多西环素、磷霉素、左氧氟沙星、利福平及万古霉素对甲氧西林敏感金黄色葡萄球菌的体外活性
Rev Esp Quimioter. 2006 Sep;19(3):252-7.
5
Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.用万古霉素和地塞米松治疗实验性葡萄球菌性心内膜炎后,主动脉瓣破坏程度较轻的证据。
Antimicrob Agents Chemother. 2001 Dec;45(12):3531-7. doi: 10.1128/AAC.45.12.3531-3537.2001.
6
The role of vancomycin in the treatment paradigm.万古霉素在治疗模式中的作用。
Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S51-7. doi: 10.1086/491714.
7
Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.生物膜对万古霉素单独以及与替加环素和利福平联合使用时针对金黄色葡萄球菌的体外活性的影响。
J Antimicrob Chemother. 2009 Mar;63(3):485-8. doi: 10.1093/jac/dkn513. Epub 2008 Dec 24.
8
Antibiotic use in neonatal sepsis.新生儿败血症中的抗生素使用。
Turk J Pediatr. 1998 Jan-Mar;40(1):17-33.
9
[Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].[万古霉素在严重金黄色葡萄球菌感染治疗中的应用。3例病例描述]
Minerva Med. 1984 Feb 28;75(8):385-90.
10
Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌长期菌血症期间万古霉素和达托霉素敏感性降低
Diagn Microbiol Infect Dis. 2008 Apr;60(4):437-40. doi: 10.1016/j.diagmicrobio.2007.11.002. Epub 2007 Dec 21.